Keeping pace with parvovirus b19 genetic variability: A multiplex genotype-specific quantitative pcr assay

Journal of Clinical Microbiology

Volumn 51, Issue 11, 2013, Pages 3753-3759

  Bonvicini, Francesca ^a   Manaresi, Elisabetta ^a   Bua, Gloria ^a   Venturoli, Simona ^b   Gallinella, Giorgio ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA;

ARTICLE; BIOINFORMATICS; CLINICAL PROTOCOL; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; GENE AMPLIFICATION; GENETIC VARIABILITY; GENOTYPE; HUMAN PARVOVIRUS B19; HYDROLYSIS; LIMIT OF DETECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS; VIRAL GENETICS;

DNA PRIMERS; DNA, VIRAL; GENETIC VARIATION; GENOTYPE; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 84886498095     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01970-13     Document Type: Article

References (27)

1. Gallinella G.2013.Parvovirus B19 achievements and challenges.ISRN Virol.doi:10.5402/2013/898730.
2. King A, Lefkowitz E, Adams M, Carstens E (ed).2011.Ninth report of the International Committee on Taxonomy of Viruses.Elsevier, New York, NY.
3. Gallinella G, Venturoli S, Manaresi E, Musiani M, Zerbini M.2003.B19 virus genome diversity: epidemiological and clinical correlations.J. Clin. Virol.28:1-13.
4. Servant A, Laperche S, Lallemand F, Marinho V, De Saint Maur G, Meritet JF, Garbarg-Chenon A.2002.Genetic diversity within human erythroviruses: identification of three genotypes.J. Virol.76:9124-9134.
5. Toan NL, Duechting A, Kremsner PG, Song le H, Ebinger M, Aberle S, Binh VQ, Duy DN, Torresi J, Kandolf R, Bock CT.2006.Phylogenetic analysis of human parvovirus B19, indicating two subgroups of genotype 1 in Vietnamese patients.J.Gen.Virol.87:2941-2949.
6. Parsyan A, Szmaragd C, Allain JP, Candotti D.2007.Identification and genetic diversity of two human parvovirus B19 genotype 3 subtypes.J.Gen.Virol. 88:428-431.
7. Cohen BJ, Gandhi J, Clewley JP.2006.Genetic variants of parvovirus B19 identified in the United Kingdom: implications for diagnostic testing.J. Clin. Virol.36:152-155.
8. Corcoran C, Hardie D, Yeats J, Smuts H.2010.Genetic variants of human parvovirus B19 in South Africa: cocirculation of three genotypes and identification of a novel subtype of genotype 1.J. Clin. Microbiol.48:137-142.
9. Hubschen JM, Mihneva Z, Mentis AF, Schneider F, Aboudy Y, Grossman Z, Rudich H, Kasymbekova K, Sarv I, Nedeljkovic J, Tahita MC, Tarnagda Z, Ouedraogo JB, Gerasimova AG, Moskaleva TN, Tikhonova NT, Chitadze N, Forbi JC, Faneye AO, Otegbayo JA, Charpentier E, Muller CP.2009.Phylogenetic analysis of human parvovirus B19 sequences from eleven different countries confirms the predominance of genotype 1 and suggests the spread of genotype 3b.J. Clin. Microbiol.47:3735-3738.
10. Liefeldt L, Plentz A, Klempa B, Kershaw O, Endres AS, Raab U, Neumayer HH, Meisel H, Modrow S.2005.Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3.J.Med.Virol.75:161-169.
11. Ekman A, Hokynar K, Kakkola L, Kantola K, Hedman L, Bonden H, Gessner M, Aberham C, Norja P, Miettinen S, Hedman K, Soderlund-Venermo M.2007.Biological and immunological relations among human parvovirus B19 genotypes 1 to 3.J. Virol.81:6927-6935.
12. Modrow S, Wenzel JJ, Schimanski S, Schwarzbeck J, Rothe U, Oldenburg J, Jilg W, Eis-Hubinger AM.2011.Prevalence of nucleic acid sequences specific for human parvoviruses, hepatitis A and hepatitis E viruses in coagulation factor concentrates.Vox Sang.100:351-358.
13. Parsyan A, Candotti D.2007.Human erythrovirus B19 and blood transfusion-an update.Transfus.Med.17:263-278.
14. Baylis SA.2008.Standardization of nucleic acid amplification technique (NAT)-based assays for different genotypes of parvovirus B19: a meeting summary.Vox Sang.94:74-80.
15. Baylis SA, Ma L, Padley DJ, Heath AB, Yu MW, Collaborative Study Group.2012.Collaborative study to establish a World Health Organization International genotype panel for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assays.Vox Sang.102:204-211.
16. Gallinella G, Bonvicini F, Filippone C, Delbarba S, Manaresi E, Zerbini M, Musiani M.2004.Calibrated real-time PCR for evaluation of parvovirus B19 viral load.Clin. Chem.50:759-762.
17. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT.2009.The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments.Clin. Chem.55:611-622.
18. Norja P, Eis-Hubinger AM, Soderlund-Venermo M, Hedman K, Simmonds P.2008.Rapid sequence change and geographical spread of human parvovirus B19: comparison of B19 virus evolution in acute and persistent infections.J. Virol.82:6427-6433.
19. Shackelton LA, Holmes EC.2006.Phylogenetic evidence for the rapid evolution of human B19 erythrovirus.J. Virol.80:3666-3669.
20. Molenaar-de Backer MW, Lukashov VV, van Binnendijk RS, Boot HJ, Zaaijer HL.2012.Global co-existence of two evolutionary lineages of parvovirus B19 1a, different in genome-wide synonymous positions.PLoS One 7:e43206.doi:10.1371/ journal.pone.0043206.
21. Suzuki M, Yoto Y, Ishikawa A, Tsutsumi H.2009.Analysis of nucleotide sequences of human parvovirus B19 genome reveals two different modes of evolution, a gradual alteration and a sudden replacement: a retrospective study in Sapporo, Japan, from 1980 to 2008.J. Virol.83:10975-10980.
22. Norja P, Hokynar K, Aaltonen LM, Chen R, Ranki A, Partio EK, Kiviluoto O, Davidkin I, Leivo T, Eis-Hubinger AM, Schneider B, Fischer HP, Tolba R, Vapalahti O, Vaheri A, Soderlund-Venermo M, Hedman K.2006.Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue.Proc. Natl. Acad. Sci. U.S.A.103:7450-7453.
23. Knoester M, von dem Borne PA, Vossen AC, Kroes AC, Claas EC.2012.Human parvovirus B19 genotype 3 associated with chronic anemia after stem cell transplantation, missed by routine PCR testing.J. Clin. Virol.54:368-370.
24. Koppelman MH, Rood IG, Fryer JF, Baylis SA, Cuypers HT.2007.Parvovirus B19 genotypes 1 and 2 detection with real-time polymerase chain reaction assays.Vox Sang.93:208-215.
25. Baylis SA, Buchheit KH.2009.A proficiency testing study to evaluate laboratory performance for the detection of different genotypes of parvovirus B19.Vox Sang.97:13-20.
26. Baylis SA, Shah N, Minor PD.2004.Evaluation of different assays for the detection of parvovirus B19 DNA in human plasma.J. Virol. Methods 121:7-16.
27. Hokynar K, Norja P, Laitinen H, Palomaki P, Garbarg-Chenon A, Ranki A, Hedman K, Soderlund-Venermo M.2004.Detection and differentiation of human parvovirus variants by commercial quantitative real-time PCR tests.J. Clin. Microbiol.42:2013-2019.